L&K Biomed Ltd. (KOSDAQ:156100)

Market Cap	272.33B
Revenue (ttm)	40.33B
Net Income (ttm)	5.84B
Shares Out	21.79M
EPS (ttm)	265.47
PE Ratio	47.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	501,559
Average Volume	376,577
Open	12,500
Previous Close	12,870
Day's Range	12,100 - 12,860
52-Week Range	5,570 - 15,930
Beta	0.73
RSI	46.59
Earnings Date	Mar 12, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2008
• Employees: 60
• Stock Exchange: KOSDAQ
• Ticker Symbol: 156100